|
|
Article: Chiron and ZymeQuest(R) form Partnership for Enzyme Conversion Of Red Blood Cells; - System would convert non-O red blood cells to universal-donor red blood cells -.
- Article from:
- PR Newswire
- Article date:
- January 5, 2004
CopyrightCOPYRIGHT 2004 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Chiron Corporation and ZymeQuest(R) Inc. announced today that they have formed a partnership to develop and commercialize ZymeQuest's enzymatic conversion system, which converts groups A, B and AB red blood cells to enzyme-converted group O (ECO(R)) red blood cells. Under the terms of the agreement, Chiron will share in the costs of developing and commercializing the enzymatic conversion system. In addition, Chiron will make an equity investment in ZymeQuest and obtain worldwide marketing and commercial rights for the technology. ZymeQuest will continue to be responsible for developing and manufacturing its enzyme conversion products. Financial terms of the agreement ...